BALDWIN BROTHERS LLC/MA - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 5 filers reported holding REVANCE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALDWIN BROTHERS LLC/MA ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$4,395
-23.4%
5000.0%0.00%
Q3 2023$5,735
-88.7%
500
-75.0%
0.00%
-100.0%
Q2 2023$50,620
+214.3%
2,000
+300.0%
0.00%
+300.0%
Q1 2023$16,105
+74.5%
5000.0%0.00%0.0%
Q4 2022$9,230
-34.1%
5000.0%0.00%
-50.0%
Q3 2022$14,000
+100.0%
5000.0%0.00%
+100.0%
Q2 2022$7,000
-30.0%
5000.0%0.00%0.0%
Q1 2022$10,0005000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders